Literature DB >> 20004001

CD81 protein is expressed at high levels in normal germinal center B cells and in subtypes of human lymphomas.

Robert F Luo1, Shuchun Zhao, Robert Tibshirani, June H Myklebust, Mrinmoy Sanyal, Rosemary Fernandez, Dita Gratzinger, Robert J Marinelli, Zhi Shun Lu, Anna Wong, Ronald Levy, Shoshana Levy, Yasodha Natkunam.   

Abstract

CD81 is a tetraspanin cell surface protein that regulates CD19 expression in B lymphocytes and enables hepatitis C virus infection of human cells. Immunohistologic analysis in normal hematopoietic tissue showed strong staining for CD81 in normal germinal center B cells, a cell type in which its increased expression has not been previously recognized. High-dimensional flow cytometry analysis of normal hematopoietic tissue confirmed that among B- and T-cell subsets, germinal center B cells showed the highest level of CD81 expression. In more than 800 neoplastic tissue samples, its expression was also found in most non-Hodgkin lymphomas. Staining for CD81 was rarely seen in multiple myeloma, Hodgkin lymphoma, or myeloid leukemia. In hierarchical cluster analysis of diffuse large B-cell lymphoma, staining for CD81 was most similar to other germinal center B cell-associated markers, particularly LMO2. By flow cytometry, CD81 was expressed in diffuse large B-cell lymphoma cells independent of the presence or absence of CD10, another germinal center B-cell marker. The detection of CD81 in routine biopsy samples and its differential expression in lymphoma subtypes, particularly diffuse large B-cell lymphoma, warrant further study to assess CD81 expression and its role in the risk stratification of patients with diffuse large B-cell lymphoma. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20004001      PMCID: PMC2813949          DOI: 10.1016/j.humpath.2009.07.022

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  31 in total

1.  Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning.

Authors:  Margaret A Shipp; Ken N Ross; Pablo Tamayo; Andrew P Weng; Jeffery L Kutok; Ricardo C T Aguiar; Michelle Gaasenbeek; Michael Angelo; Michael Reich; Geraldine S Pinkus; Tane S Ray; Margaret A Koval; Kim W Last; Andrew Norton; T Andrew Lister; Jill Mesirov; Donna S Neuberg; Eric S Lander; Jon C Aster; Todd R Golub
Journal:  Nat Med       Date:  2002-01       Impact factor: 53.440

2.  Cutting edge: dynamic redistribution of tetraspanin CD81 at the central zone of the immune synapse in both T lymphocytes and APC.

Authors:  María Mittelbrunn; María Yáñez-Mó; David Sancho; Angeles Ursa; Francisco Sánchez-Madrid
Journal:  J Immunol       Date:  2002-12-15       Impact factor: 5.422

3.  Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes.

Authors:  Izidore S Lossos; Debra K Czerwinski; Ash A Alizadeh; Mark A Wechser; Rob Tibshirani; David Botstein; Ronald Levy
Journal:  N Engl J Med       Date:  2004-04-29       Impact factor: 91.245

4.  CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.

Authors:  Bertrand Coiffier; Eric Lepage; Josette Briere; Raoul Herbrecht; Hervé Tilly; Reda Bouabdallah; Pierre Morel; Eric Van Den Neste; Gilles Salles; Philippe Gaulard; Felix Reyes; Pierre Lederlin; Christian Gisselbrecht
Journal:  N Engl J Med       Date:  2002-01-24       Impact factor: 91.245

5.  Analysis of MUM1/IRF4 protein expression using tissue microarrays and immunohistochemistry.

Authors:  Y Natkunam; R A Warnke; K Montgomery; B Falini; M van De Rijn
Journal:  Mod Pathol       Date:  2001-07       Impact factor: 7.842

Review 6.  Hepatitis C virus (HCV) and lymphomagenesis.

Authors:  Wen-Kai Weng; Shoshana Levy
Journal:  Leuk Lymphoma       Date:  2003-07

7.  Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray.

Authors:  Christine P Hans; Dennis D Weisenburger; Timothy C Greiner; Randy D Gascoyne; Jan Delabie; German Ott; H Konrad Müller-Hermelink; Elias Campo; Rita M Braziel; Elaine S Jaffe; Zenggang Pan; Pedro Farinha; Lynette M Smith; Brunangelo Falini; Alison H Banham; Andreas Rosenwald; Louis M Staudt; Joseph M Connors; James O Armitage; Wing C Chan
Journal:  Blood       Date:  2003-09-22       Impact factor: 22.113

8.  The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.

Authors:  Andreas Rosenwald; George Wright; Wing C Chan; Joseph M Connors; Elias Campo; Richard I Fisher; Randy D Gascoyne; H Konrad Muller-Hermelink; Erlend B Smeland; Jena M Giltnane; Elaine M Hurt; Hong Zhao; Lauren Averett; Liming Yang; Wyndham H Wilson; Elaine S Jaffe; Richard Simon; Richard D Klausner; John Powell; Patricia L Duffey; Dan L Longo; Timothy C Greiner; Dennis D Weisenburger; Warren G Sanger; Bhavana J Dave; James C Lynch; Julie Vose; James O Armitage; Emilio Montserrat; Armando López-Guillermo; Thomas M Grogan; Thomas P Miller; Michel LeBlanc; German Ott; Stein Kvaloy; Jan Delabie; Harald Holte; Peter Krajci; Trond Stokke; Louis M Staudt
Journal:  N Engl J Med       Date:  2002-06-20       Impact factor: 91.245

9.  The tetraspanin CD81 regulates the expression of CD19 during B cell development in a postendoplasmic reticulum compartment.

Authors:  Tsipi Shoham; Ranjani Rajapaksa; Claude Boucheix; Eric Rubinstein; Jonathan C Poe; Thomas F Tedder; Shoshana Levy
Journal:  J Immunol       Date:  2003-10-15       Impact factor: 5.422

10.  Semi-supervised methods to predict patient survival from gene expression data.

Authors:  Eric Bair; Robert Tibshirani
Journal:  PLoS Biol       Date:  2004-04-13       Impact factor: 8.029

View more
  16 in total

1.  Identification of the tetraspanin CD82 as a new barrier to xenotransplantation.

Authors:  Soad M Saleh; Ranjit S Parhar; Reem S Al-Hejailan; Razan H Bakheet; Hala S Khaleel; Hanif G Khalak; Anason S Halees; Marya Z Zaidi; Brian F Meyer; Gisella P Yung; Jörg D Seebach; Walter Conca; Khalid S Khabar; Kate S Collison; Futwan A Al-Mohanna
Journal:  J Immunol       Date:  2013-07-19       Impact factor: 5.422

2.  New developments in the pathology of malignant lymphoma: a review of the literature published from October 2009 to January 2010.

Authors:  J Han van Krieken
Journal:  J Hematop       Date:  2010-06-02       Impact factor: 0.196

3.  Flow Cytometric Evaluation of Traditional and Novel Surface Markers for the Diagnosis of Plasma Cell Dyscrasias.

Authors:  Dominik F Draxler; Lisa M Wutzlhofer; Georg Slavka; Wolfgang Hübl; Heinz Ludwig; Martin Schreder; John Reynolds; Martin Willheim
Journal:  Indian J Hematol Blood Transfus       Date:  2019-03-07       Impact factor: 0.900

4.  Flow-Cytometry in the Diagnosis of Diffuse Large B-Cell Lymphoma Based on Stomach Tissue Samples: A Case Report.

Authors:  Tung Tuan Nguyen; An Thi Vinh Do; Nga Thi Nguyen; Thanh Quoc Truong; Ai Thuc Ton
Journal:  Cureus       Date:  2022-01-31

5.  CD81 is a candidate tumor suppressor gene in human gastric cancer.

Authors:  Tae-Hyoung Yoo; Byung-Kyu Ryu; Min-Goo Lee; Sung-Gil Chi
Journal:  Cell Oncol (Dordr)       Date:  2012-12-21       Impact factor: 6.730

6.  Increased expression of CD81 is associated with poor prognosis of prostate cancer and increases the progression of prostate cancer cells in vitro.

Authors:  Yu Zhang; Haining Qian; An Xu; Ganggang Yang
Journal:  Exp Ther Med       Date:  2019-11-26       Impact factor: 2.447

7.  Tetraspanin CD37 protects against the development of B cell lymphoma.

Authors:  Charlotte M de Winde; Sharon Veenbergen; Ken H Young; Zijun Y Xu-Monette; Xiao-Xiao Wang; Yi Xia; Kausar J Jabbar; Michiel van den Brand; Alie van der Schaaf; Suraya Elfrink; Inge S van Houdt; Marion J Gijbels; Fons A J van de Loo; Miranda B Bennink; Konnie M Hebeda; Patricia J T A Groenen; J Han van Krieken; Carl G Figdor; Annemiek B van Spriel
Journal:  J Clin Invest       Date:  2016-01-19       Impact factor: 14.808

8.  Super-SILAC allows classification of diffuse large B-cell lymphoma subtypes by their protein expression profiles.

Authors:  Sally J Deeb; Rochelle C J D'Souza; Jürgen Cox; Marc Schmidt-Supprian; Matthias Mann
Journal:  Mol Cell Proteomics       Date:  2012-03-21       Impact factor: 5.911

Review 9.  Tetraspanins: Novel Molecular Regulators of Gastric Cancer.

Authors:  Yue Deng; Sicheng Cai; Jian Shen; Huiming Peng
Journal:  Front Oncol       Date:  2021-06-18       Impact factor: 6.244

10.  Meningeal B Cell Clusters Correlate with Submeningeal Pathology in a Natural Model of Multiple Sclerosis.

Authors:  Molly E Church; Guadalupe Ceja; Megan McGeehan; Miles C Miller; Priscilla Farias; Melissa D Sánchez; Gary P Swain; Charles-Antoine Assenmacher; Edward G Stopa; Charles H Vite; Amit Bar-Or; Jorge I Alvarez
Journal:  J Immunol       Date:  2021-06-23       Impact factor: 5.426

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.